212 related articles for article (PubMed ID: 29127442)
21. Corticosteroid inhibits chemokines production in systemic sclerosis patients.
Dantas AT; de Almeida AR; Sampaio MCPD; Cordeiro MF; da Rocha LF; de Oliveira PSS; Pereira MC; de Melo Rego MJB; Marques CDL; da Rocha Pitta I; Duarte ALBP; da Rocha Pitta MG
Steroids; 2017 Nov; 127():24-30. PubMed ID: 28866045
[TBL] [Abstract][Full Text] [Related]
22. Microbial Toll-like receptor ligands differentially regulate CXCL10/IP-10 expression in fibroblasts and mononuclear leukocytes in synergy with IFN-gamma and provide a mechanism for enhanced synovial chemokine levels in septic arthritis.
Proost P; Vynckier AK; Mahieu F; Put W; Grillet B; Struyf S; Wuyts A; Opdenakker G; Van Damme J
Eur J Immunol; 2003 Nov; 33(11):3146-53. PubMed ID: 14579283
[TBL] [Abstract][Full Text] [Related]
23. Treatment of monocytes with interleukin (IL)-12 plus IL-18 stimulates survival, differentiation and the production of CXC chemokine ligands (CXCL)8, CXCL9 and CXCL10.
Coma G; Peña R; Blanco J; Rosell A; Borras FE; Esté JA; Clotet B; Ruiz L; Parkhouse RM; Bofill M
Clin Exp Immunol; 2006 Sep; 145(3):535-44. PubMed ID: 16907924
[TBL] [Abstract][Full Text] [Related]
24. Abnormal expression of intracellular cytokines and chemokine receptors in peripheral blood T lymphocytes from patients with systemic sclerosis.
Fujii H; Hasegawa M; Takehara K; Mukaida N; Sato S
Clin Exp Immunol; 2002 Dec; 130(3):548-56. PubMed ID: 12452848
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary capillary endothelial dysfunction in early systemic sclerosis.
Orfanos SE; Psevdi E; Stratigis N; Langleben D; Catravas JD; Kyriakidis M; Moutsopoulos HM; Roussos C; Vlachoyiannopoulos PG
Arthritis Rheum; 2001 Apr; 44(4):902-11. PubMed ID: 11315930
[TBL] [Abstract][Full Text] [Related]
26. Respiratory syncytial virus infection of primary human mast cells induces the selective production of type I interferons, CXCL10, and CCL4.
Al-Afif A; Alyazidi R; Oldford SA; Huang YY; King CA; Marr N; Haidl ID; Anderson R; Marshall JS
J Allergy Clin Immunol; 2015 Nov; 136(5):1346-54.e1. PubMed ID: 25819983
[TBL] [Abstract][Full Text] [Related]
27. The Long Non-coding RNA NRIR Drives IFN-Response in Monocytes: Implication for Systemic Sclerosis.
Mariotti B; Servaas NH; Rossato M; Tamassia N; Cassatella MA; Cossu M; Beretta L; van der Kroef M; Radstake TRDJ; Bazzoni F
Front Immunol; 2019; 10():100. PubMed ID: 30804934
[TBL] [Abstract][Full Text] [Related]
28. The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis.
Brkic Z; van Bon L; Cossu M; van Helden-Meeuwsen CG; Vonk MC; Knaapen H; van den Berg W; Dalm VA; Van Daele PL; Severino A; Maria NI; Guillen S; Dik WA; Beretta L; Versnel MA; Radstake T
Ann Rheum Dis; 2016 Aug; 75(8):1567-73. PubMed ID: 26371289
[TBL] [Abstract][Full Text] [Related]
29. Rapid differentiation of monocytes into type I IFN-producing myeloid dendritic cells as an antiviral strategy against influenza virus infection.
Cao W; Taylor AK; Biber RE; Davis WG; Kim JH; Reber AJ; Chirkova T; De La Cruz JA; Pandey A; Ranjan P; Katz JM; Gangappa S; Sambhara S
J Immunol; 2012 Sep; 189(5):2257-65. PubMed ID: 22855715
[TBL] [Abstract][Full Text] [Related]
30. Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis.
Wohlfahrt T; Usherenko S; Englbrecht M; Dees C; Weber S; Beyer C; Gelse K; Distler O; Schett G; Distler JH; Ramming A
Ann Rheum Dis; 2016 Mar; 75(3):623-6. PubMed ID: 26338035
[TBL] [Abstract][Full Text] [Related]
31. Plasma Chemokine signature correlates with lung goblet cell hyperplasia in smokers with and without chronic obstructive pulmonary disease.
Kim V; Cornwell WD; Oros M; Durra H; Criner GJ; Rogers TJ
BMC Pulm Med; 2015 Sep; 15():111. PubMed ID: 26424214
[TBL] [Abstract][Full Text] [Related]
32. Sera from patients with active systemic lupus erythematosus patients enhance the toll-like receptor 4 response in monocyte subsets.
Carvalheiro T; Gomes D; Pinto LA; Inês L; Lopes A; Henriques A; Pedreiro S; Martinho A; Trindade H; Young HA; da Silva JA; Paiva A
J Inflamm (Lond); 2015; 12():38. PubMed ID: 26038677
[TBL] [Abstract][Full Text] [Related]
33. Interferon-γ and tumor necrosis factor-α sustain secretion of specific CXC chemokines in human thyrocytes: a first step toward a differentiation between autoimmune and tumor-related inflammation?
Rotondi M; Coperchini F; Pignatti P; Sideri R; Groppelli G; Leporati P; La Manna L; Magri F; Mariotti S; Chiovato L
J Clin Endocrinol Metab; 2013 Jan; 98(1):308-13. PubMed ID: 23118425
[TBL] [Abstract][Full Text] [Related]
34. The exaggerated inflammatory response in Behçet's syndrome: identification of dysfunctional post-transcriptional regulation of the IFN-γ/CXCL10 IP-10 pathway.
Ambrose N; Khan E; Ravindran R; Lightstone L; Abraham S; Botto M; Johns M; Haskard DO
Clin Exp Immunol; 2015 Sep; 181(3):427-33. PubMed ID: 25982097
[TBL] [Abstract][Full Text] [Related]
35. Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis.
Tang J; Lei L; Pan J; Zhao C; Wen J
Rheumatol Int; 2018 Aug; 38(8):1511-1519. PubMed ID: 29846790
[TBL] [Abstract][Full Text] [Related]
36. Identification of Siglec-1-negative alveolar macrophages with proinflammatory phenotypes in chronic obstructive pulmonary disease.
Saito T; Fujino N; Kyogoku Y; Yamada M; Okutomo K; Ono Y; Konno S; Endo T; Itakura K; Matsumoto S; Sano H; Aizawa H; Numakura T; Onodera K; Okada Y; Hussell T; Ichinose M; Sugiura H
Am J Physiol Lung Cell Mol Physiol; 2024 Jun; 326(6):L672-L686. PubMed ID: 38530936
[TBL] [Abstract][Full Text] [Related]
37. Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors.
Ciechomska M; Huigens CA; Hügle T; Stanly T; Gessner A; Griffiths B; Radstake TR; Hambleton S; O'Reilly S; van Laar JM
Ann Rheum Dis; 2013 Aug; 72(8):1382-9. PubMed ID: 23223421
[TBL] [Abstract][Full Text] [Related]
38. Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin.
Mathes AL; Christmann RB; Stifano G; Affandi AJ; Radstake TR; Farina GA; Padilla C; McLaughlin S; Lafyatis R
Ann Rheum Dis; 2014 Oct; 73(10):1864-72. PubMed ID: 23873879
[TBL] [Abstract][Full Text] [Related]
39. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
Raschi E; Chighizola CB; Cesana L; Privitera D; Ingegnoli F; Mastaglio C; Meroni PL; Borghi MO
Arthritis Res Ther; 2018 Aug; 20(1):187. PubMed ID: 30157947
[TBL] [Abstract][Full Text] [Related]
40. CXCL10 is produced in hepatitis A virus-infected cells in an IRF3-dependent but IFN-independent manner.
Sung PS; Hong SH; Lee J; Park SH; Yoon SK; Chung WJ; Shin EC
Sci Rep; 2017 Jul; 7(1):6387. PubMed ID: 28744018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
